about
Opioids, pain, the brain, and hyperkatifeia: a framework for the rational use of opioids for painCXCR4 signaling mediates morphine-induced tactile hyperalgesia.Complications of long-term opioid therapy for management of chronic pain: the paradox of opioid-induced hyperalgesiaThe mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependenceCarbamazepine potentiates the effectiveness of morphine in a rodent model of neuropathic painBrainstem control of cerebral blood flow and application to acute vasospasm following experimental subarachnoid hemorrhage.Metabolic changes in the rodent brain after acute administration of salvinorin A.Opioid-induced latent sensitization in a model of non-inflammatory viscerosomatic hypersensitivity.Spinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways.Gabapentin improves cold-pressor pain responses in methadone-maintained patients.Lack of effect of chronic dextromethorphan on experimental pain tolerance in methadone-maintained patients.Sex differences in kappa opioid pharmacologyClarifying the roles of homeostasis and allostasis in physiological regulation.1-(4-Methoxy-phen-yl)-3-phenyl-1H-pyrazol-5-amine.Heterologous regulation of Mu-opioid (MOP) receptor mobility in the membrane of SH-SY5Y cells.Effectiveness of local anesthesia with lidocaine in chronic opium abusers.Proton sharing and transfer in some zwitterionic compounds based on 4-oxo-4-((1-phenethylpiperidin-4-yl)(phenyl)amino)alcanoic acids.In vivo phenotypic screening for treating chronic neuropathic pain: modification of C2-arylethynyl group of conformationally constrained A3 adenosine receptor agonists.Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine.Regulation of κ-opioid receptor signaling in peripheral sensory neurons in vitro and in vivo.Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.Effects of opium addiction on level of sensory block in spinal anesthesia with bupivacaine for lower abdomen and limb surgery: a case-control study.Microglia: a promising target for treating neuropathic and postoperative pain, and morphine toleranceThe dark side of emotion: the addiction perspectiveRepeated nitrous oxide exposure in rats causes a thermoregulatory sign-reversal with concurrent activation of opposing thermoregulatory effectors.Drug-induced regulatory overcompensation has motivational consequences: Implications for homeostatic and allostatic models of drug addiction.D-cycloserine reduces neuropathic pain behavior through limbic NMDA-mediated circuitryDevelopment of mechanical hypersensitivity in rats during heroin and ethanol dependence: alleviation by CRF₁ receptor antagonism.Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A3 adenosine receptor agonist that protects against chronic neuropathic pain.Pronociceptive and Antinociceptive Effects of Buprenorphine in the Spinal Cord Dorsal Horn Cover a Dose Range of Four Orders of Magnitude.TRPV1 receptor in expression of opioid-induced hyperalgesiaMost recent developments and modifications of 14-alkylamino and 14-alkoxy-4,5-epoxymorphinan derivativesOpioid analgesics and P-glycoprotein efflux transporters: a potential systems-level contribution to analgesic tolerance.Antinociception of petroleum ether fraction derived from crude methanol extract of Melastoma malabathricum leaves and its possible mechanisms of action in animal models.NLRP12 Inflammasome Expression in the Rat Brain in Response to LPS during Morphine Tolerance.Sex-specific mediation of opioid-induced hyperalgesia by the melanocortin-1 receptor.Magnesium sulphate attenuate remifentanil-induced postoperative hyperalgesia via regulating tyrosine phosphorylation of the NR2B subunit of the NMDA receptor in the spinal cordRegion-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine tolerance.The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia.Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking the development of morphine antinociceptive tolerance through peroxynitrite-mediated pathways.
P2860
Q24605135-364436CD-85B1-48E6-AD94-0E47AA3AB77CQ24624133-1DFE6D85-C1DD-4555-878B-99C830B8E04BQ24631654-BAFAF77E-1CBE-4067-8B67-80B2CFE41436Q26801420-B5B8690C-BE30-4D1A-A459-937F7587FCD2Q28542981-486945FE-F0BD-40C2-B24A-A0B97F435C3DQ30490018-DB8D3974-0D33-4F6E-A9A3-A049987ECD8DQ30490227-15567F37-5D42-4DE5-915A-490118FCC474Q33640173-83E8716F-9842-40DD-BBF9-2DFBD92A33FFQ33640240-B1B1D2AD-E2CF-4403-A8E2-CCB0C7AA7BFAQ33872764-65AD9FF5-4C2B-4A2C-90C8-30E8ED9E02A3Q34119496-D694CB2C-24BD-49A1-BEB8-6003B75F3E57Q34144003-CF83E776-D348-4F3A-A7E0-5D1FF3ADD3FBQ34200223-C7DEA67E-521C-4F2A-B7A0-0CC1DFFB1971Q34295831-A5104AD4-D128-4E19-B43D-043A19355D9CQ34317508-289729FD-ADAE-400C-816A-156D477C218EQ34507440-B80C5CD6-38D3-48E6-9D05-6891462087DAQ34560595-4F668E35-EEA1-4880-91F3-86CF3A99A7B9Q34701441-3422A319-7E8B-4650-9D64-01CFD7F2C362Q35049134-9DFE4CB3-C074-4F19-AAAB-C16AAF51E7AFQ35077913-798A7B47-981F-4DDA-A1B1-ACE5EDECDD1EQ35122783-E84978C8-1D81-4684-A49A-626EDEC56510Q35173152-8E3772EC-6969-4D2A-BE6C-40E1DDF6AC7DQ35204830-B4CD6258-7687-432A-A6C9-A77E21099B5FQ35235813-2D01CE9B-3A63-4872-A0E4-DCB08C021731Q35552194-DB9A4089-3EA9-4B42-B31F-48E27B37B6D4Q35557145-FBDF04A7-E350-473F-895D-B3BAC0CAF645Q35575120-2288203F-72C5-4458-8ACC-B94F7272EE14Q35685680-BF33847D-CD4B-401A-872C-D2C6EBDC8E29Q35930748-63183222-D1A6-4B29-B97B-386CA66AFD65Q36064141-5801536D-3FD6-48EA-B579-9CB7B3BC0FAFQ36066010-BDEEF9E7-EB4D-4A33-BF16-B1A587299000Q36107406-D75EDCBA-0B3E-4936-98E4-65E7157B7FFDQ36107418-F3F6BC24-2173-469A-8BC8-04DDBB04F5C5Q36207122-8AC09EDF-7F1B-4A2B-B332-697EEBFEC2A6Q36273965-2E34FA27-4F80-4D84-B90A-475F196AC623Q36274644-F01A1931-3462-4761-BA72-1C75544A66CFQ36286713-89871E6D-57C4-4AF4-85FE-5D07F32CEB04Q36358112-92CFDC67-FD26-49CE-ABEB-FED2285BC186Q36968245-5449CDA5-AD6C-4681-BC33-A3F2315B34F8Q37131042-F1A2762B-37EA-4CE7-9CBE-ECC0122EE569
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Antinociceptive and nociceptive actions of opioids.
@ast
Antinociceptive and nociceptive actions of opioids.
@en
type
label
Antinociceptive and nociceptive actions of opioids.
@ast
Antinociceptive and nociceptive actions of opioids.
@en
prefLabel
Antinociceptive and nociceptive actions of opioids.
@ast
Antinociceptive and nociceptive actions of opioids.
@en
P2093
P2860
P356
P1476
Antinociceptive and nociceptive actions of opioids.
@en
P2093
Frank Porreca
Josephine Lai
Michael H Ossipov
T Philip Malan
Tamara King
Todd W Vanderah
Victor J Hruby
P2860
P304
P356
10.1002/NEU.20091
P577
2004-10-01T00:00:00Z